» Articles » PMID: 17506495

BDNF-mediated Modulation of GABA and Glycine Release in Dorsal Horn Lamina II from Postnatal Rats

Overview
Journal Dev Neurobiol
Specialties Biology
Neurology
Date 2007 May 18
PMID 17506495
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies show that excitatory glutamatergic transmission is potentiated by BDNF in superficial dorsal horn, both at the pre- and the postsynaptic site. The role of BDNF in modulating GABA and glycine-mediated inhibitory transmission has not been fully investigated. To determine whether the neurotrophin is effective in regulating the spontaneous release of the two neurotransmitters, we have recorded miniature inhibitory postsynaptic currents (mIPSCs) in lamina II of post-natal rats. We show that application of BDNF enhanced the spontaneous release of GABA and glycine, in presence of tetrodotoxin. The effect was blocked by the trk-receptor inhibitor k-252a. Amplitude and kinetics of mIPSCs were not altered. Evoked GABA and glycine IPSCs (eIPSCs) were depressed by BDNF and the coefficient of variation of eIPSC amplitude was significantly increased. By recording glycine eIPSCs with the paired-pulse protocol, an increase of paired-pulse ratio during BDNF application was observed. We performed parallel ultrastructural studies to unveil the circuitry involved in the effects of BDNF. These studies show that synaptic interactions between full length functional trkB receptors and GABA-containing profiles only occur at non peptidergic synaptic glomeruli of types I and II. Expression of trkB in presynaptic vesicle-containing dendrites originating from GABAergic islet cells, indicates these profiles as key structures in the modulation of inhibitory neurotransmission by the neurotrophin. Our results thus describe a yet uncharacterized effect of BDNF in lamina II, giving further strength to the notion that the neurotrophin plays an important role in pain neurotransmission.

Citing Articles

Brain-Derived Neurotrophic Factor, Nociception, and Pain.

Merighi A Biomolecules. 2024; 14(5).

PMID: 38785946 PMC: 11118093. DOI: 10.3390/biom14050539.


Neuroinflammation alters GABAergic neurotransmission in hyperammonemia and hepatic encephalopathy, leading to motor incoordination. Mechanisms and therapeutic implications.

Llansola M, Arenas Y, Sancho-Alonso M, Mincheva G, Palomares-Rodriguez A, Doverskog M Front Pharmacol. 2024; 15:1358323.

PMID: 38560359 PMC: 10978603. DOI: 10.3389/fphar.2024.1358323.


Neuropathic pain; what we know and what we should do about it.

Smith P Front Pain Res (Lausanne). 2023; 4:1220034.

PMID: 37810432 PMC: 10559888. DOI: 10.3389/fpain.2023.1220034.


Effects of the Co-Overexpression of the and Genes on the Gamma-Aminobutyric Acid-Ergic Differentiation of Wharton's-Jelly-Derived Mesenchymal Stem Cells.

Borkowska P, Morys J, Zielinska A, Kowalski J Biomedicines. 2023; 11(6).

PMID: 37371846 PMC: 10296716. DOI: 10.3390/biomedicines11061751.


BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB Signaling Pathway through Activating GABA Receptor.

Liu B, Guan F, Zhao J, Niu Y, Jiang H Oxid Med Cell Longev. 2022; 2022:4661519.

PMID: 36439691 PMC: 9691330. DOI: 10.1155/2022/4661519.